Sotalol hydrochloride is the active ingredient in Betapace
AF, a treatment for irregular heart rhythms made by Schering AG unit Berlex Inc.
Other launches during 2004 include seven strengths of Amphetamines Mixed Salts tablets (reference: Adderall tablets, Shire Pharmaceuticals Group), Sotalol AF tablets (reference: Betapace
AF tablets, Berlex Laboratories), Phentermine 37.
Berlex Laboratories, which markets the drug as Betapace
, filed a supplemental application for approval of this indication.
Drug treatments include Cordarone (amiodarone), Corvert (ibutilide), Tambocor (flecainide), Rythmol (propafenone), Cardioquine (quinidine), Betapace
(sotalol) and Tikosyn (dofetilide).
The drug is presently available only in a twice daily formulation as Betapace
(R) and Betapace
AF(TM) (Berlex) as well as generics.
Anti-arrhythmia medications such asTambocor, Rhythmol, Procanbid, Betapace
, Norpace, or Quinidex